Filing Details
- Accession Number:
- 0001415889-23-010966
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-07-07 18:00:16
- Reporting Period:
- 2023-07-06
- Accepted Time:
- 2023-07-07 18:00:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1798749 | Aerovate Therapeutics Inc. | AVTE | Pharmaceutical Preparations (2834) | 831377888 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1869248 | T Benjamin Dake | C/O Aerovate Therapeutics, Inc. 930 Winter Street, Suite M-500 Waltham MA 02451 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-07-06 | 2,412 | $1.74 | 3,703 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-07-06 | 7,871 | $2.14 | 11,574 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-07-06 | 10,283 | $16.66 | 1,291 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-07-06 | 906 | $0.00 | 906 | $1.74 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-07-06 | 1,506 | $0.00 | 1,506 | $1.74 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-07-06 | 1,019 | $0.00 | 1,019 | $2.14 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-07-06 | 6,852 | $0.00 | 6,852 | $2.14 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,433 | 2030-09-03 | No | 4 | M | Direct | |
| 19,589 | 2030-09-03 | No | 4 | M | Direct | |
| 21,386 | 2031-04-01 | No | 4 | M | Direct | |
| 157,609 | 2031-04-01 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.31 to $17.225, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- A total of 48,293 shares subject to an employee stock option were granted on September 4, 2020, with 10% of the shares vested on January 1, 2020, an additional 22.5% of theshares vested on January 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter.
- A total of 72,325 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter.
- A total of 48,882 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on May 2, 2021, with shares vesting in 48 substantially equal monthly installments.
- A total of 328,921 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on July 4, 2021, and with shares vesting in 48 substantially equal monthly installments.
Billionaire Hedge Funds
